IP Library Granted Patent US 8,173,860
Granted Patent B2
US 8,173,860 · App. 11/788,775 · Granted May 8, 2012

Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,173,860
App. No.
11/788,775
Granted
May 8, 2012
Kind
B2
Abstract

The invention provides, in part, methods for the production of proteins in a transgenic non-human mammal, wherein the proteins are transported from the blood to the mammary gland for secretion in milk. The transport of the protein to the mammary gland and/or milk is facilitated by binding to a transport receptor in the mammary gland.

Claims (16)

1. A non-human transgenic mammal whose genome comprises a DNA sequence encoding human FcRn and a DNA sequence encoding beta-microglobulin operably linked to a mammary gland-specific promoter, and further comprises a DNA sequence encoding a transgenic protein comprising a human Fc-domain operably linked to a non-mammary gland-specific promoter.

2. The non-human mammal of claim 1 , wherein the non-mammary gland-specific promoter is a liver-specific promoter.

3. The non-human mammal of claim 2 , wherein the liver-specific promoter is an albumin promoter.

4. The non-human mammal of claim 1 , wherein the transgenic protein is an antibody.

5. A composition comprising milk obtained from the non-human mammal of claim 1 .

6. A method for obtaining a transgenic protein comprising a human Fc-domain, comprising:

generating a non-human transgenic mammal whose genome comprises a DNA sequence encoding human FcRn and a DNA sequence encoding beta-microglobulin operably linked to a mammary gland-specific promoter, and further comprises a DNA sequence encoding transgenic protein comprising a human Fc-domain operably linked to a non-mammary gland-specific promoter,

wherein the transgenic protein comprising a human Fc-domain binds the functional human FcRn via the human Fc-domain,

collecting milk from the non-human mammal, and

separating the transgenic protein comprising a human Fc-domain from the milk.

7. The method of claim 6 , wherein the non-mammary gland-specific promoter is a liver-specific promoter.

8. The method of claim 7 , wherein the liver-specific promoter is an albumin promoter.

9. The method of claim 6 , wherein the transgenic protein comprising a human Fc-domain is an antibody.

10. A composition comprising the collected milk of the method of claim 6 .

11. A composition comprising milk from a non-human transgenic mammal whose genome comprises a DNA sequence encoding human FcRn and a DNA sequence encoding beta-microglobulin operably linked to a mammary gland-specific promoter, and further comprises a DNA sequence encoding a transgenic protein comprising a human Fc-domain operably linked to a non-mammary gland-specific promoter.

12. The composition of claim 11 , wherein the glycosylation pattern of the transgenic protein is different from the glycosylation pattern of the protein when expressed in the mammary gland of the non-human mammal.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032845/0955 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2014
From: LFB BIOTECHNOLOGIES S.A.S.U.
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032448/0045 →
RELEASE OF SECURITY INTEREST Recorded Mar 11, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032424/0230 →
CHANGE OF NAME Recorded Jul 18, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 030831/0075 →
SECURITY AGREEMENT Recorded Jan 16, 2009
From: GTC BIOTHERAPEUTICS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 022119/0854 →
SECURITY AGREEMENT Recorded Dec 22, 2008
From: GTC BIOTHERAPEUTICS, INC.
To: LFB BIOTECHNOLOGIES S.A.S.U.
Reel/Frame 022019/0205 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2007
From: MEADE, HARRY M.; POLLOCK, DANIEL
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 020135/0019 →